The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer
Boehringer Ingelheim GMBH has advanced its biologics activity in China by inking its first human pharma research collaboration in the country with China Southeast University Institute of Life Scienc
IN VITRO DIAGNOSTICS Mergers & Acquisitions Opko Health Inc. Bio-Reference Laboratories Inc. Opko Health Inc. acquired publicly traded Bio-Reference Laboratories Inc. (BRLI; clinical laborator